U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that the first rickshaw was invented in 1869 by an American Baptist minister, the Rev. E. Jonathan Scobie, to transport his invalid wife around the streets of Yokohama?

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 548/365.7 - The additional hetero ring contains chalcogen as the only ring hetero atom


Subclass of Class 548 - Organic compounds -- part of the class 532-570 series
Definition: Compounds containing chalcogen (i.e., oxygen, sulfur, selenium,
No. of patents: 316
Last issue date: 02/05/2013


1                
NumberTitleIssue Date
8367846Method of producing 2-alkyl-3-aminothiophene derivative
The present invention provides a method of producing 2-alkyl-3-aminothiophene derivative represented by Formula (4), the method comprising oxidizing a compound represented by the following Formula (1) to produce a compound represented by the following Formula (3) an...
02/05/2013
8318951Stem cell differentiating agents and uses therefor
The present invention relates to screens for compounds that can induce stem cell differentiation. In addition, isoxazoles and sulfonyl hydrazones are identified as general classes of compounds that can induce differentiation of stem cells into cells of neuronal and ...
11/27/2012
8227620Pharmaceutical compounds
Pyrazole derivatives of the following formula (I), having affinity for the cannabinoidergic CB1 and/or CB2 receptors: wherein: R is a group selected from C
07/24/2012
80977321-arylpyrazoles and their use as pesticide
Disclosed are compounds of formula (I) or pesticidally acceptable salts thereof, wherein, for example, W is ═N—, ═CH—, ═CR7— or ═C(NR8R9)—, R7 is halogen, R8 and R9 are independently o...
01/17/2012
7659407Pharmaceutical compounds
Pyrazole derivatives of the following formula (I), having affinity for the cannabinoidergic CB1 and/or CB2 receptors: wherein: R is a group selected from: C
02/09/2010
7456295Bis(thienyl)isopyrazoles and process for preparing and method for using bis(thienyl)isopyrazoles
The present invention demonstrates the synthesis of a new pyrazole-containing monomer by means of an easily implemented two-step process. This monomer can be electropolymerized to yield a stable n-doping polymer that may easily be electrochemically characterized. It...
11/25/2008
7396944Thiophene derivatives, their manufacture and use as pharmaceutical agents
Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as we...
07/08/2008
7396929Synthesis of 3-amino-4-substituted pyrazole derivatives
This application discloses a novel process to synthesize 3-amino-4-substituted pyrazole derivatives, which may be used, for example, as intermediates to prepare compounds having, for example, pharmaceutical utility. ...
07/08/2008
7348342Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
We describe substituted benzenesulfoximine compounds having anti-inflammatory activity, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of inflammatory diseases. ...
03/25/2008
7265112Small molecule modulators of hepatocyte growth factor (scatter factor) activity
The present invention provides compounds having formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1, R2 and B are as described generally and in classes and subclasse...
09/04/2007
7247635Pyrazole derivative
Drugs, in particular, pyrazole derivatives represented by the following general formula (I) which have a calcium release-dependent calcium channel inhibitory effect and medicinal compositions, in particular, calcium release-dependent calcium channel inhibitors conta...
07/24/2007
7244757Pyrazole-amine compounds for the treatment of neurodegenerative disorders
The present invention relates to compounds of the Formula wherein R1, R3, R4, R5, R6, R7 and R8 are as defined...
07/17/2007
7241793Phenyloxyalkanonic acid derivatives as hPPAR activators
A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, wherein: ...
07/10/2007
RE396811-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2
Compounds of the formula wherein: X is selected from the group consisting of trihalomethyl, C1-C6 alkyl, and a group of formula II: ...
06/05/2007
7195649N-aryl-4,5-diaminopyrazoles and dyes containing said compounds
N-Aryl-4,5-diaminopyrazole of formula (I) or a physiologically compatible salt thereof of an organic or inorganic acid wherein R1 and R2 independently of each other denote a hydrogen atom, a straight...
03/27/2007
7192976Small molecule modulators of hepatocyte growth factor (scatter factor) activity
The present invention provides compounds having formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1, R2 and B are as described generally and...
03/20/2007
7173129Sulfonamide-substituted chalcone derivatives and their use to treat diseases
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the ...
02/06/2007
7148226Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The ...
12/12/2006
7138361Herbicidal heterocycles
Compounds of Formula (1), their N-oxides and agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation wherein A, R1, R2...
11/21/2006
7105564Pharmaceutical composition comprising a dual antagonist against PGD/TXAreceptors having a [2.2.1] or [3.1.1] bicyclic skeleton
The present invention provides novel compounds having a dual antagonistic activity against thromboxane A2 receptor and prostaglandin D2 receptor and pharmaceutical compositions comprising them. A compound of the formula (I):
09/12/2006
7091350Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
The invention relates to diaminopyrazole derivatives having the following structure (I), wherein R1 represents an alkyl or alkenyl radical bearing at least one substituent selected from among OR, NRR′, SR, SOR, SO2R, COOR, CONRR′, PO(OH)
08/15/2006
7078531Process for obtaining enantiomers of thienylazolylalcoxyethanamines
A process is described for the preparation of a precursor alcohol of (±)-2-[thienyl(1-methyl-1H-pyrazol-5-yl)methoxy]-N,N-dimethyletanamine and in general for thienylazolylalcoxyethanamines and their enantiomers. The process involves asymmetric addition of a metala...
07/18/2006
7034154Synthesis of substituted pyrazolopyrimidines
Methods of making substituted pyrazolopyrimidines generally and, more particularly, N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide. Such compounds have utility over a wide range of indications, including treatment of insomnia. ...
04/25/2006
70340493(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
Compounds which are 3-amino-pyrazole derivatives represented by formula (I) wherein R is C3–C6 cycloalkyl group optionally substituted by a straight or branched C1–C6 alkyl or arylalkyl group; R1 is a straig...
04/25/2006
6998415Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase, such as inflammation. ...
02/14/2006
6979742Process for obtaining enantiomers of thienylazolylalcoxyethanamines
A process is described for the preparation of a precursor alcohol of (±)-2-[thienyl(1-methyl-1H-pyrazol-5-yl)methoxy]-N,N-dimethyletanamine, and more generally for thyenylazolylalcoxyethanamines and their enantiomers. The process involves the asymmetric reduction o...
12/27/2005
6965036Intermediates for guanidine mimics as factor Xa inhibitors
The present application describes intermediates for nitrogen containing heteroaromatics and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein rings D—E represent guanidine m...
11/15/2005
6958339Pyrazole derivative
The present invention is directed to drugs, in particular, pyrazole derivatives represented by the following general formula (I) which have a calcium release-activated calcium channel inhibitory effect and medicinal co...
10/25/2005
6949536Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
This invention provides a compound of the formula: or its pharmaceutically acceptable salt thereof, wherein A is partially unsaturated or unsaturated five membered heterocyclic, or partially unsaturated or unsaturated ...
09/27/2005
6916798Inhibitors of GSK-3 and uses thereof
The present invention relates to compounds of formula I that are useful as GSK-3 inhibitors. The invention also relates to methods of using compounds of formula I or pharmaceutical compositions comprising compounds of formula I to inhibit GSK-3 activity. The inventi...
07/12/2005
6911452Spiroazacyclic compounds as monoamine receptor modulators
The present invention relates to 1-oxa-3,8-diaza-spiro[4.5]decan-2-one compounds as monoamine receptor modulators; compositions comprising the same; methods of inhibiting an activity of a monoamine receptor with said compounds; methods of treating a disease conditio...
06/28/2005
6897232Pyrazole derivatives, their preparation and their use in pharmaceuticals
The present invention relates to pyrazole derivatives of the formula I, their preparation and their use in pharmaceuticals: in which X, R1, R1a, R2, R3, R4 and n a...
05/24/2005
6706711Pyrazole derived kinase inhibitor
Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein R1, R2, T, n and Q are as described in the specification. The compounds are useful for treatin...
03/16/2004
6660732Compounds useful as anti-inflammatory agents
Disclosed are novel aromatic compounds which are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are pharmaceutical compositions containing and processes of making such c...
12/09/2003
6656933Compounds useful as anti-inflammatory agents
Disclosed are novel aromatic compounds which are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are pharmaceutical compositions containing and processes of making such c...
12/02/2003
6610726Compositions and agents for modulating cellular proliferation and angiogenesis
The invention is directed to pharmaceutical compositions containing small organic molecules having the ability to mimic or agonize hepatocyte growth factor/scatter factor (HGF/SF) activity, useful for promoting, for example, vascularization of tissues or ...
08/26/2003
6605637Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
The invention concerns novel lipoic acid derivatives, which have an inhibiting action with respect to NO-synthase enzymes producing nitrogen monoxide NO and/or are agents enabling the regeneration of antioxidants or entities trapping reactive oxygen speci...
08/12/2003
6593358Thienyl-pyrazoles and their use for controlling pests
The present invention relates to compounds of the formulae (Ia) and (Ib) ##STR1## wherein R1 represents C1-10 alkyl which may be unsubstituted or substituted with halogen, or represents C2-4 alkoxyalkyl, C2-4 hy...
07/15/2003
6593357Pyrazole compositions useful as inhibitors of ERK
Described herein are compounds that are useful as protein kinase inhibitors having the formula: ##STR1## where R1-4, Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviate...
07/15/2003
6569860Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
This invention relates to compounds which are IP receptor antagonists and which are represented by Formula (I): ##STR1## wherein G2 is a heteroaryl group containing one or two nitrogen atoms substituted with a carboxylic acid group, said hetero...
05/27/2003
1                
 
Sign InRegister
Username  
Password   
forgot password?